1998
DOI: 10.1007/bf02466535
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of the precolumn bio trap 500 C18 for direct injection of plasma samples in a column-switching system

Abstract: SummaryA new restricted access media (RAM) type of precolumn, BioTrap 500 C18, for direct injection of plasma samples in column-switching systems was evaluated with respect to the elution of plasma proteins in different mobile phases, the loading capacity of plasma samples, the chromatographic behavior during plasma injections and protein contamination of the packing and sealings. More than 95 % of plasma proteins could be excluded from the precolumn within three minutes for all selected mobile phases. Quantit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2001
2001
2011
2011

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(4 citation statements)
references
References 19 publications
0
4
0
Order By: Relevance
“…As a protein-immobilized stationary phase capable of plasma direct injection, octadecylsilane (ODS) treated with human plasma was developed and plasma direct injection capability was shown by Yoshida et al 12,13 α1-Acidglycoprotein (α1-AGP)-, ovomucoid-and avidin-coated columns had been developed, [14][15][16] and are capable of plasma direct injection. [17][18][19][20] Furthermore, direct analysis of drugs in serum using zwitterionic bile acid derivative-coated ODS was reported by Umemura et al 21 Several polymer-modified reversed-phase column materials such as the shielded hydrophobic phase (SHP) and the semipermeable surface (SPS) had also been reported. 8,[22][23][24] SHP consists of a hydrophilic, polymeric, water-solvated phase, covalently bonded to a silica bed.…”
Section: Introductionmentioning
confidence: 99%
“…As a protein-immobilized stationary phase capable of plasma direct injection, octadecylsilane (ODS) treated with human plasma was developed and plasma direct injection capability was shown by Yoshida et al 12,13 α1-Acidglycoprotein (α1-AGP)-, ovomucoid-and avidin-coated columns had been developed, [14][15][16] and are capable of plasma direct injection. [17][18][19][20] Furthermore, direct analysis of drugs in serum using zwitterionic bile acid derivative-coated ODS was reported by Umemura et al 21 Several polymer-modified reversed-phase column materials such as the shielded hydrophobic phase (SHP) and the semipermeable surface (SPS) had also been reported. 8,[22][23][24] SHP consists of a hydrophilic, polymeric, water-solvated phase, covalently bonded to a silica bed.…”
Section: Introductionmentioning
confidence: 99%
“…Using the BioTrap as precolumn for the extraction of polar drugs from plasma or serum has been thoroughly investigated [24,25]. The BioTrap 500 MS column particles are manufactured with a coating of ␣1-acid glycoprotein (AGP) on the external surface and consequently compatible with various types of protein-containing biosamples under generic conditions for either basic or acidic compounds.…”
Section: Resultsmentioning
confidence: 99%
“…Silica C 18 restricted-access matrix sorbents e¡ectively exclude plasma proteins. 33,34 A 2064 mm i.d. Bio Trap C 18 column (Chromtech) could tolerate up to 15 mL of plasma without changing retention pressure, with clogging only after 45 mL of plasma.…”
Section: Restricted-access Matrix Sorbentsmentioning
confidence: 99%